Abstract

Hepatocellular carcinoma is the fifth most common cancer in the world, and the 3rd leading cause of cancer-related death. The precise stage system of hepatocellular carcinoma, which classifies patients to the same prognosis group, is important, so that it can help to choose proper treatment strategy. Staging systems used for hepatocellular carcinoma are Okuda, TNM, CLIP, French, CUPI, JIS score and BCLC classification, these staging systems have limitations in predicting patient prognosis, because these do not include tumor morphology, characteristics, clinical variables and treatment modalities properly. The staging system of hepatocellular carcinoma is still insignificantly studied in domestic. A large scale cohort study is needed including multivariables.

• Keywords: Hepatocellular carcinoma;Staging system